CONMED CORP's ticker is CNMD and the CUSIP is 207410101. A total of 147 filers reported holding CONMED CORP in Q3 2016. The put-call ratio across all filers is 0.26 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $106,971,596 | -27.6% | 1,060,700 | -2.4% | 0.01% | -20.0% |
| Q2 2023 | $147,697,756 | +25.9% | 1,086,892 | -3.8% | 0.02% | +25.0% |
| Q1 2023 | $117,358,891 | +32.5% | 1,129,972 | +13.1% | 0.01% | +20.0% |
| Q4 2022 | $88,549,588 | +18.5% | 998,980 | +7.2% | 0.01% | +11.1% |
| Q3 2022 | $74,700,000 | +0.4% | 931,771 | +19.9% | 0.01% | +12.5% |
| Q2 2022 | $74,405,000 | +43.8% | 776,987 | +123.1% | 0.01% | +60.0% |
| Q1 2022 | $51,744,000 | -0.6% | 348,321 | -5.1% | 0.01% | 0.0% |
| Q4 2021 | $52,037,000 | +5.8% | 367,078 | -2.3% | 0.01% | 0.0% |
| Q3 2021 | $49,179,000 | +7.9% | 375,894 | +13.4% | 0.01% | 0.0% |
| Q2 2021 | $45,571,000 | +7.5% | 331,596 | +2.1% | 0.01% | 0.0% |
| Q1 2021 | $42,400,000 | +22.4% | 324,674 | +5.0% | 0.01% | +25.0% |
| Q4 2020 | $34,643,000 | +57.3% | 309,321 | +10.5% | 0.00% | +33.3% |
| Q3 2020 | $22,026,000 | +29.8% | 279,992 | +18.8% | 0.00% | 0.0% |
| Q2 2020 | $16,964,000 | +25.9% | 235,636 | +0.1% | 0.00% | +50.0% |
| Q1 2020 | $13,477,000 | -36.5% | 235,338 | +24.1% | 0.00% | -33.3% |
| Q4 2019 | $21,214,000 | +8.4% | 189,700 | -6.8% | 0.00% | 0.0% |
| Q3 2019 | $19,574,000 | +37.7% | 203,564 | +22.5% | 0.00% | +50.0% |
| Q2 2019 | $14,215,000 | -24.6% | 166,117 | -26.7% | 0.00% | -33.3% |
| Q1 2019 | $18,854,000 | +116.7% | 226,672 | +67.3% | 0.00% | +50.0% |
| Q4 2018 | $8,701,000 | -12.6% | 135,524 | +7.9% | 0.00% | 0.0% |
| Q3 2018 | $9,954,000 | +80.9% | 125,657 | +67.2% | 0.00% | +100.0% |
| Q2 2018 | $5,501,000 | +5.0% | 75,152 | -9.1% | 0.00% | 0.0% |
| Q1 2018 | $5,238,000 | +49.0% | 82,691 | +19.9% | 0.00% | 0.0% |
| Q4 2017 | $3,516,000 | -44.7% | 68,985 | -43.1% | 0.00% | 0.0% |
| Q3 2017 | $6,359,000 | +0.2% | 121,182 | -2.7% | 0.00% | 0.0% |
| Q2 2017 | $6,348,000 | +39.9% | 124,599 | +21.9% | 0.00% | 0.0% |
| Q1 2017 | $4,538,000 | +16.1% | 102,184 | +15.5% | 0.00% | 0.0% |
| Q4 2016 | $3,908,000 | -30.3% | 88,474 | -36.8% | 0.00% | 0.0% |
| Q3 2016 | $5,609,000 | +156.1% | 140,013 | +205.3% | 0.00% | 0.0% |
| Q2 2016 | $2,190,000 | +245.4% | 45,866 | +203.5% | 0.00% | – |
| Q1 2016 | $634,000 | +22.2% | 15,112 | +28.3% | 0.00% | – |
| Q4 2015 | $519,000 | -28.5% | 11,782 | -22.5% | 0.00% | – |
| Q3 2015 | $726,000 | -53.5% | 15,212 | -43.2% | 0.00% | -100.0% |
| Q2 2015 | $1,560,000 | +1128.3% | 26,772 | +963.6% | 0.00% | – |
| Q1 2015 | $127,000 | -88.0% | 2,517 | -89.3% | 0.00% | – |
| Q4 2014 | $1,060,000 | -41.8% | 23,585 | -52.3% | 0.00% | -100.0% |
| Q3 2014 | $1,821,000 | -13.7% | 49,439 | +3.4% | 0.00% | 0.0% |
| Q2 2014 | $2,111,000 | +135.3% | 47,822 | +131.7% | 0.00% | – |
| Q1 2014 | $897,000 | -32.2% | 20,636 | -33.7% | 0.00% | – |
| Q4 2013 | $1,323,000 | +55.1% | 31,128 | +23.9% | 0.00% | – |
| Q3 2013 | $853,000 | -29.0% | 25,123 | -34.6% | 0.00% | -100.0% |
| Q2 2013 | $1,201,000 | – | 38,443 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Hood River Capital Management LLC | 448,126 | $38,346,000 | 1.80% |
| HealthCor Management, L.P. | 455,190 | $38,951,000 | 1.51% |
| Champlain Investment Partners, LLC | 1,452,360 | $124,278,000 | 1.04% |
| J. Goldman & Co LP | 162,771 | $13,928,000 | 0.96% |
| Granahan Investment Management | 189,925 | $16,252,000 | 0.80% |
| PURA VIDA INVESTMENTS, LLC | 50,000 | $4,279,000 | 0.65% |
| OAK RIDGE INVESTMENTS LLC | 102,797 | $8,797,000 | 0.61% |
| LANDSCAPE CAPITAL MANAGEMENT, L.L.C. | 78,722 | $6,736,000 | 0.54% |
| MOODY ALDRICH PARTNERS LLC | 23,834 | $2,039,000 | 0.52% |
| 361 CAPITAL LLC | 30,901 | $2,644,000 | 0.47% |